European Psychiatry - Volume 41 - April 2017

264 / 916

S260 25th European Congress of Psychiatry / European Psychiatry 41S (2017) S238–S302
TARA for Borderline Personality Disorder TARA4BPD, Exec Director,
NYC, USA
Undiagnosed and untreated people with Borderline Personality
Disorder (BPD) create a public health drain on mental health
treatment. BPD underlies major public health problems including
high incidence of substance abuse, alcoholism, domestic vio-
lence, impulse control disorders, incarceration, high utilization of
emergency rooms and inpatient hospitalizations. Although BPD
has a prevalence rate between 2–5.9%, it generally goes mis-
diagnosed, undiagnosed, stigmatized and mistreated. Amongst
American veterans who are suicide attempters and completers, a
recent study found 94% meet criteria for BPD. There is rampant
professional stigma exists against BPD patients, seen as patients to
be “avoided”, “treatment refractory,” “untreatable” and a “liability”
due to increased risk of self-injurious and suicidal behavior. This is
a contributing factor to misdiagnosis that is the usual experience
for BPD patients, resulting in wasted years, hopelessness, chaos,
family crises, and severe personal and economic consequences for
patients and families. The need for assessing with validated diag-
nostic instruments to rule out or diagnose BPD, Bipolar Disorder,
ADHD, substance abuse and other co-morbid diagnoses as well as
the need to diagnosis children and adolescents at the time symp-
toms first appear will be discussed. Presentation of the shockingly
few studies on BPD versus Bipolar will be presented and the conse-
quences of failing to diagnose will be highlighted. Findings from an
on-line survey from TARA4BPD, an American education and advo-
cacy organization, will demonstrate the need for clinical education
in evidence based BPD treatments, training, and supervision as well
as patient and family psycho-education so as to improve outcome
will be presented.
Disclosure of interest The author has not supplied his/her decla-
ration of competing interest.
EW0452
Personality disorders and
temperament traits in patients with
breast disease: Preliminary results
V. Prisco ∗, T. Iannaccone , G. Di Grezia
1 University of Naples SUN, Department of Psychiatry, Naples, Italy
2 University of Naples SUN, Department of Radiology, Naples, Italy
∗ Corresponding author.
Aim of the study was to identify individual characteristics in
patients with a benign or malignant breast disease diagnosis.
The role of specific personality traits has been considered in the
assessment of temperament and character as a predictor of a
certain psychopathological state in patients with breast disease
diagnosis. Participants were interviewed using a structured clin-
ical test (SCID-II, version 2.0) disorders, and the Italian version
of Akiskal’s semi-structured clinical interview for temperamental
profiles (TEMPS-I) after clinical breast exams and ultrasonography.
All patients presented different personality disorders and hetero-
geneity in temperamental profiles. Of 29 patients with benign
breast disease diagnosis, twelve presented histrionic, seven narcis-
sistic, five dependent, four obsessive, two borderline, one antisocial
and one paranoid personality disorder. The histrionic-narcissistic
disorder is associatedwith benign breast disease. The three patients
with malignant diagnosis presented the same temperamental pro-
file: depressive temperamentwas associatedwithmalignant breast
disease diagnosis. According to recent literature personality dis-
orders cannot influence breast cancer or its prognosis. However,
a psychological consultation represent a very important step to
pre-dispose specific interventions, treating psychiatric reactive
co-morbidities. The study shows the relevance of psychiatric coun-
selling in breast units in the diagnostic cluster detection. Future
purpose is to extend the sample and to add a follow-up evaluation.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
EW0453
Hyperprolactinemia phenomenon in
neurotic and personality disorders
and changes in prolactin level after
the psychotherapy
K. Rutkowski ∗, E. Dembinska , J. Sobanski , K. Cyranka ,
A. Citkowska-Kisielewska , M. Mielimaka
Jagiellonian University Medical College, Department. of
Psychotherapy, Krakow, Poland
∗ Corresponding author.
Introduction Hyperprolactinemia is a common endocrinological
disorder. Some data suggest that psychological factors (e.g. person-
ality traits) may play a role in hyperprolactinemia genesis.
Objectives Increased prolactin level (PRL) is described as clinical
observations in some patients, usually with a diagnosis of border-
line personality disorder. In the international literature there is lack
of broader description and information of clinical implications of
this phenomenon.
Aim The aim of the study is to evaluate the prevalence of hyper-
prolactinemia in patients with diagnoses F40-F69 according to
ICD-10 and an evaluation of the changes in PRL after psychotherapy.
Methods The study population comprised 64 patients, mainly
females (73%), with primary diagnosis of neurotic or personality
disorder. Prolactin level was measured during the first and last
week of the psychotherapy. Between the measurements patients
underwent intensive short-term (12 weeks) group psychotherapy
in a day hospital for neurotic and behavioural disorders.
Results Hyperprolactinemia was found in 41% of males and 42.4%
of females in the study group. After psychotherapy significant
reduction in prolactin level was observed in 80% of woman with
hyperprolactinemia.
Conclusions Hyperprolactinemia is observed in almost 40% of
patients with neurotic and personality disorders. Psychodynamic
psychotherapy can be a significant factor improving PRL level
in patients with neurotic and personality disorders, specifically
women.
Disclosure of interest The authors have not supplied their decla-
ration of competing interest.
e-Poster Walk: Psychopathology and
Psychotherapy
EW0454
DBT for co-morbid borderline
personality disorder and substance
use disorder without drug
replacement in Egyptian outpatient
settings: A non-randomized trial
A. Abdelkarim ∗, T. Molokhia , A. Rady , A. Ivanoff
1 Alexandria Faculty of Medicine, Neuropsychiatry, Alexandria, Egypt
2 Columbia University, School of Social Work, New York, USA
∗ Corresponding author.
Background Dialectical behavior therapy has demonstrated
effectiveness for patients suffering from co-morbid borderline per-
sonality and substance use disorder. The current study tries to